Pharmacological evaluation of selected arylpiperazines with atypical antipsychotic potential
- 1 August 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (16) , 4263-4266
- https://doi.org/10.1016/j.bmcl.2004.06.005
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Serotonin receptors : their key role in drugs to treat schizophreniaProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2003
- Does Fast Dissociation From the Dopamine D2Receptor Explain the Action of Atypical Antipsychotics?: A New HypothesisAmerican Journal of Psychiatry, 2001
- The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?Journal of Psychopharmacology, 2001
- The Role of Serotonin in Antipsychotic Drug ActionNeuropsychopharmacology, 1999
- Linking the Family of D2 Receptors to Neuronal Circuits in Human Brain: Insights into SchizophreniaNeuropsychopharmacology, 1997
- Antipsychotic drugs: recent developments and novel agentsExpert Opinion on Therapeutic Patents, 1997
- Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypyPharmacology Biochemistry and Behavior, 1988
- A novel procedure for dissociating the anatomical bases of the behavioral effects of amphetaminePharmacology Biochemistry and Behavior, 1987
- A rapid and simple behavioural screening method for simultaneous assessment of limbic and striatal blocking effects of neuroleptic drugsPharmacology Biochemistry and Behavior, 1985
- Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypyPharmacology Biochemistry and Behavior, 1984